Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
12.73
-0.46 (-3.49%)
Mar 9, 2026, 4:00 PM EDT - Market closed
COEP Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 72 | 11 | 27 | 30 | 2,494 | 338 | |
| Market Cap Growth | 130.18% | -57.71% | -10.53% | -98.80% | 637.84% | - | |
| Enterprise Value | 67 | 12 | 26 | 26 | 2,497 | - | |
| Last Close Price | 12.73 | 5.50 | 15.68 | 30.63 | 200.00 | 203.80 | |
| PS Ratio | 144.33 | - | - | - | 33258.23 | 10990.00 | |
| PB Ratio | 6.33 | 2.92 | 32.85 | 6.71 | 1061.15 | -65.73 | |
| P/TBV Ratio | 7.90 | 4.28 | 32.85 | 6.71 | 1061.15 | - | |
| EV/Sales Ratio | 134.25 | - | - | - | 33296.44 | - | |
| Debt / Equity Ratio | 0.03 | 0.36 | 1.50 | 0.46 | 1.74 | -0.41 | |
| Net Debt / Equity Ratio | -0.46 | 0.22 | -0.30 | -0.39 | 0.81 | -0.37 | |
| Net Debt / EBITDA Ratio | 0.42 | -0.10 | 0.01 | 0.05 | -0.14 | -0.29 | |
| Net Debt / FCF Ratio | 0.61 | -0.13 | 0.03 | 0.45 | -0.42 | -0.60 | |
| Asset Turnover | 0.04 | - | - | - | 0.02 | 0.03 | |
| Quick Ratio | 2.00 | 0.12 | 0.51 | 1.75 | 0.79 | 0.04 | |
| Current Ratio | 2.21 | 0.23 | 0.59 | 1.81 | 0.79 | 0.04 | |
| Return on Equity (ROE) | -171.91% | -464.73% | -807.49% | -1104.48% | - | - | |
| Return on Assets (ROA) | -71.41% | -93.24% | -215.14% | -291.15% | -248.47% | -451.53% | |
| Return on Capital Employed (ROCE) | -115.20% | -228.80% | -1358.10% | -595.40% | -351.10% | 134.80% | |
| Earnings Yield | -17.13% | -86.79% | -79.54% | -125.73% | -0.54% | -2.71% | |
| FCF Yield | -11.55% | -58.80% | -27.08% | -12.97% | -0.18% | -0.93% | |
| Buyback Yield / Dilution | 82.00% | -49.84% | -79.70% | -30.98% | -79.11% | -18.53% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.